Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed
Rhea-AI Filing Summary
Shattuck Labs Chief Technical Officer Abhinav A. Shukla reported option-related trades in the company’s common stock. On June 30 and July 1, he exercised stock options covering a total of 23,465 shares at an exercise price of $3.57 per share.
The same total of 23,465 shares of common stock was sold in open-market transactions at weighted average prices of about $7.08 and $7.07 per share, under a pre-arranged Rule 10b5-1 trading plan intended to fund the option exercise price and estimated tax withholding. After these transactions, he directly holds 86,380 shares of common stock and continues to hold unexercised portions of an option covering up to 52,200 shares that vests through January 25, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 100 | $0.00 | $0.00 |
| Exercise | Common Stock | 100 | $3.57 | $357.00 |
| Sale | Common Stock | 100 | $7.07 | $707.00 |
| Exercise | Stock Option (Right to Buy) | 23,365 | $0.00 | $0.00 |
| Exercise | Common Stock | 23,365 | $3.57 | $83K |
| Sale | Common Stock | 23,365 | $7.08 | $165K |
Footnotes (3)
- F1. Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026. The plan is intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding associated with option exercises under the plan. Under the procedures of the administering broker, acquired shares are first sold to fund the aggregate exercise price and estimated tax withholding with respect to all possible option exercises in a particular order under the plan and only once fully funded will acquired shares be held by the Reporting Person.
- F2. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.00 to $7.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. This option represents a right to purchase a total of 52,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (Right to Buy) financial
exercise or conversion of derivative security financial
tax withholding financial
vesting financial
FAQ
Did the Shattuck Labs CTO exercise stock options in this Form 4?
What is the size and vesting schedule of the CTO’s STTK option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.